Low-dose methotrexate controls a severe form of polyarteritis nodosa

Archives of Dermatology

Volumn 136, Issue 2, 2000, Pages 167-169

  Boehm, Ingrid ^a   Bauer, Ralf ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; MALE; PHYSICAL EXAMINATION; POLYARTERITIS NODOSA; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0033952713     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.136.2.167     Document Type: Article

References (14)

1. Lightfoot RW, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088-1093.
2. Hoffman GS. Wegener's granulomatosis. Curr Opin Rheumatol. 1993;5:11-17.
3. Mevorach D, Leibowitz G, Brezis M, et al. Induction of remission in a patient with Takayasu's arteritis by low dose pulses of methotrexate. Ann Rheumatol Dis. 1992; 51:904-905.
4. Hernandez-Garcia C, Soriano C, Morado C, et al. Methotrexate treatment in the management of giant cell arteritis. Scand J Rheumatol. 1994;23:295-298.
5. Jorizzo JL, White WL, Wise CM, et al. Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease. J Am Acad Dermatol. 1991;24:973-978.
6. Tannenbaum H. Combined therapy with methotrexate and prednisone in polyarteritis nodosa. CMAJ. 1980;123:893-894.
7. Boehm I, Bauer R. Low-dose methotrexate: an immunomodifying therapeutic strategy for dermatologic diseases. In: Burg G, Dummer R, eds. Strategies for Immunointerventions in Dermatology. New York, NY: Springer Verlag NY Inc; 1997: 59-70.
8. Martinez-Osuna P, Zwolinska JB, Sikes DH, et al. Lack of immunosuppressive effect of low-dose oral methotrexate on lymphocytes in rheumatoid arthritis. Clin Exp Rheumatol. 1993;11:249-253.
9. Segal R, Mozes E, Yaron M, et al. The effect of methotrexate on the production and activity of interleukin 1. Arthritis Rheum. 1989;32:370-377.
10. Chang DM, Baptiste P, Schur PH. The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 inhibitor production by human monocytes. J Rheumatol. 1990;17:1148-1157.
11. Rordorf-Adam C, Lazdins J, Woods-Cook K, et al. An assay for the detection of interleukin-1 synthesis inhibitor: effects of antirheumatic drugs. Drugs Exp Clin Res. 1989;15:355-362.
12. Brody M, Böhm I, Bauer R. Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1β to the interleukin 1 receptor on target cells. Eur J Clin Chem Clin Biochem. 1993;31:667-674.
13. Suarez CR, Pickett WC, Bell DH, et al. Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a. J Rheumatol. 1987;14:9-11
14. Asako H, Wolf RE, Granger DN. Leukocyte adherence in rat mesenteric venules: effects of adenosine and methotrexate. Gastroenterology. 1993;104:31-37.